Adage Capital Partners
TTOO

Adage Capital Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Adage Capital Partners’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-80
Closed -$1.05M – 768
2019
Q1 		$1.05M Hold
80
– – ﹤0.01% 659
2018
Q4 		$1.2M Buy
80
+40
+100% +$940K ﹤0.01% 674
2018
Q3 		$1.49M Buy
+40
New +$1.32M ﹤0.01% 680
2017
Q4 		– Sell
-20
Closed -$420K – 763
2017
Q3 		$420K Buy
+20
New +$371K ﹤0.01% 702

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners's TTOO Position: Q2 2019 in Review

Adage Capital Partners sold out of T2 Biosystems, Inc (TTOO) in Q2 2019, closing a stake of 80 shares — an estimated $1.05M sold.

Adage Capital Partners first reported a position in TTOO in Q3 2017 and held it in 4 quarters. The position peaked at $1.49M in Q3 2018. 63 funds tracked by Wall St. Rank hold TTOO as of Q2 2019.

  • Adage Capital Partners reported no remaining T2 Biosystems, Inc position as of Q2 2019 after selling out during the quarter.
  • Adage Capital Partners sold 80 T2 Biosystems, Inc shares in Q2 2019, an estimated $1.05M.
  • Adage Capital Partners first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 4 quarters.
  • Adage Capital Partners's T2 Biosystems, Inc position peaked at $1.49M in Q3 2018.
  • 63 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2019.

Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.